| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia |
|
Medicine details |
|
| Medicine name | sodium zirconium cyclosilicate (Lokelma®) |
| Formulation | 5 g and 10g powder for oral suspension |
| Reference number | 2444 |
| Indication | Treatment of hyperkalaemia in adult patients |
| Company | AstraZeneca UK Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 05/06/2018 |
| NICE guidance | TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia |